REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

KORIS PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KORIS PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

KORIS PHARMA Kft. is an enterprise based in Hungary. Its main office is in Kiskoros. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on January 10, 2015. 4 (2024) employees currently work for KORIS PHARMA Kft.. From the latest financial highlights, KORIS PHARMA Kft. reported a net sales revenue increase of 4.43% in 2023. Its total assets grew by 8.5% over the same period. In 2023, KORIS PHARMA Kft.’s net profit margin increased by 0.11%.

Headquarters
Rakoczi Ferenc utca 9.
Kiskoros; Bacs-Kiskun; Postal Code: 6200

Contact Details: Purchase the KORIS PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the KORIS PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the KORIS PHARMA Kft. report to view the information.
Registered Capital:
Purchase the KORIS PHARMA Kft. report to view the information.
Incorporation Date:
January 10, 2015
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after KORIS PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
4.43%▲
Total operating revenue
4.37%▲
Operating profit (EBIT)
-2.64%▼
EBITDA
-1.71%▼
Net Profit (Loss) for the Period
5.58%▲
Total assets
8.5%▲
Total equity
6.03%▲
Operating Profit Margin (ROS)
-0.8%▼
Net Profit Margin
0.11%▲
Return on Equity (ROE)
-0.37%▼
Quick Ratio
-0.42%▼
Cash Ratio
-0.49%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo